Ultralow‐dose rituximab in pemphigus: a single‐centre experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ultralow‐dose rituximab in pemphigus: a single‐centre experience

Published:2021-11-30 Issue: Volume: Page:
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Simpson K.¹^ORCID,Low Z.M.¹,Yap T.¹²,Kern J.S.¹²,Scardamaglia L.¹²³⁴^ORCID

Affiliation:

1. Department of Dermatology The Royal Melbourne Hospital Parkville VIC Australia

2. Faculty of Medicine University of Melbourne Dentistry and Health Sciences Parkville VIC Australia

3. Department of Dermatology Western Health Footscray VIC Australia

4. Department of Dermatology The Royal Children’s Hospital Parkville VIC Australia

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.20819

Reference8 articles.

1. Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens

2. Low-dose rituximab is effective in pemphigus

3. First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

4. Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing

5. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of low-dose rituximab to treat pemphigus;Anais Brasileiros de Dermatologia;2024-09

2. Updates on the Management of Autoimmune Bullous Diseases;Indian Dermatology Online Journal;2024-08-30

3. Unexpected B lymphocytes depletion in a patient with pemphigus vulgaris after a single dose of 50 mg rituximab;The Journal of Dermatology;2024-05-22

4. The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study;Journal of Dermatological Treatment;2024-01-22

5. Three cases of refractory bullous pemphigoid in the elderly treated successfully with ultra‐low‐dose rituximab;The Journal of Dermatology;2022-12-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3